Antibiotic influx and efflux in Pseudomonas aeruginosa : Regulation and therapeutic implications
Microbial Biotechnology · 2024-05 · 17 (5)
DOI: 10.1111/1751-7915.14487 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Microbial Biotechnology, online erschienen am 27.05.2024. Verfasst von Weiyan Wu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Guangdong Province Key Laboratory of Microbial Signals and Disease Control, Integrative Microbiology Research Centre, South China Agricultural Univer…. Hauptthemen laut MEDLINE: Pseudomonas aeruginosa, Anti-Bacterial Agents, Gene Expression Regulation, Bacterial, Membrane Transport Proteins. Die Arbeit wurde bisher 67-mal zitiert (Crossref) und nennt 174 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Guangdong Basic and Applied Basic Research Foundation, Basic and Applied Basic Research Foundation of Guangdong Province.
Abstract (Originalsprache)
Pseudomonas aeruginosa is a notorious multidrug‐resistant pathogen that poses a serious and growing threat to the worldwide public health. The expression of resistance determinants is exquisitely modulated by the abundant regulatory proteins and the intricate signal sensing and transduction systems in this pathogen. Downregulation of antibiotic influx porin proteins and upregulation of antibiotic efflux pump systems owing to mutational changes in their regulators or the presence of distinct inducing molecular signals represent two of the most efficient mechanisms that restrict intracellular antibiotic accumulation and enable P. aeruginosa to resist multiple antibiotics. Treatment of P. aeruginosa infections is extremely challenging due to the highly inducible mechanism of antibiotic resistance. This review comprehensively summarizes the regulatory networks of the major porin proteins (OprD and OprH) and efflux pumps (MexAB‐OprM, MexCD‐OprJ, MexEF‐OprN, and MexXY) that play critical roles in antibiotic influx and efflux in P. aeruginosa . It also discusses promising therapeutic approaches using safe and efficient adjuvants to enhance the efficacy of conventional antibiotics to combat multidrug‐resistant P. aeruginosa by controlling the expression levels of porins and efflux pumps. This review not only highlights the complexity of the regulatory network that induces antibiotic resistance in P. aeruginosa but also provides important therapeutic implications in targeting the inducible mechanism of resistance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Guangdong Province Key Laboratory of Microbial Signals and Disease Control, Integrative Microbiology Research Centre, South China Agricultural University, Guangzhou, China.
ORCID-Profile: Zeling Xu
Förderung
- National Natural Science Foundation of China
- Guangdong Basic and Applied Basic Research Foundation
- Basic and Applied Basic Research Foundation of Guangdong Province
Zitieren
APA
Wu, W., Huang, J., & Xu, Z. (2024). Antibiotic influx and efflux in Pseudomonas aeruginosa : Regulation and therapeutic implications. Microbial Biotechnology, 17(5). https://doi.org/10.1111/1751-7915.14487
Vancouver
Wu W, Huang J, Xu Z. Antibiotic influx and efflux in Pseudomonas aeruginosa : Regulation and therapeutic implications. Microbial Biotechnology. 2024;17(5). doi:10.1111/1751-7915.14487
BibTeX
@article{Wu2024,
author = {Wu, Weiyan and Huang, Jiahui and Xu, Zeling},
title = {Antibiotic influx and efflux in Pseudomonas aeruginosa : Regulation and therapeutic implications},
journal = {Microbial Biotechnology},
year = {2024},
volume = {17},
number = {5},
doi = {10.1111/1751-7915.14487}
}
EUVIMED